Anavex Life Sciences Corp (AVXL)

[kund]

Wow! I received 9 medals today...

I liked this paragraph the most :

The Sigma-1 receptor angle isn’t new. It’s been kicked around academic literature for decades, with sporadic claims of neuroprotective potential — mostly in petri dishes. No drug built on this mechanism has ever reached commercial success.
Anavex capitalized on that scientific gray zone. The company repurposed a compound first synthesized in the 1990s, layered it with pseudoscientific jargon about “precision medicine” and “biomarker-guided therapy,” and convinced retail investors that it was the next Aricept.
What they really built was a narrative engine, not a drug program.